Health ❯ Healthcare ❯ Pharmaceuticals

Drug Pricing

Weight Loss Drugs Medicare Generic Drugs Prescription Drugs Weight Loss Medications Discount Programs Novo Nordisk Medicare Negotiations GLP-1 Medications Market Competition

9 ARTICLES

last wk.

U.S. Opens Section 301 Probe Into Germany's Drug Pricing

The inquiry seeks to determine whether German reimbursement rules unfairly depress payments for innovative medicines, potentially paving the way for tariffs or other trade remedies.

3 ARTICLES

last mo.

Germany Rules No Added Benefit for New Alzheimer Antibodies After Major Review Finds Little Effect

3 ARTICLES

2mo ago

Senate Report Says Drugmakers Raised Prices Despite Trump Deals

16 ARTICLES

2mo ago

Dosing Disputes, Counterfeits, and a Patent Wall Put Keytruda Under Fresh Scrutiny

3 ARTICLES

2mo ago

Keytruda’s Price Faces New Scrutiny in Germany After Spending Tops €2 Billion

9 ARTICLES

2mo ago

Trump Imposes Up to 100% Tariffs on Patented Drugs With Paths to Lower Rates

4 ARTICLES

2mo ago

AbbVie, Genentech Join TrumpRx With Deep Discounts on Humira and Xofluza

5 ARTICLES

2mo ago

Emcure Slashes Price of Novo’s Semaglutide Brand Poviztra by Up to 55% in India

6 ARTICLES

2mo ago

Brazil Overhauls Obesity Drug Guidance as FDA Approves Lilly’s Daily Pill

11 ARTICLES

3mo ago

Brazil Sets 2026 Medicine Price Caps With Three-Tier Increases Up to 3.81%

3 ARTICLES

3mo ago

Pakistan Drug Regulator Denies Fresh Hikes for Essential Medicines

Drug Pricing

U.S. Opens Section 301 Probe Into Germany's Drug Pricing

Canada Expands Access to Semaglutide With Home Delivery and First G7 Generics

White House Projects $529 Billion in Savings From Trump’s MFN Drug Pricing Plan

NPPA Caps Retail Prices for 42 Drug Formulations

Pakistan Approves Prices for 35 Essential Drugs to Ease Shortages

Trump Seals Regeneron Drug-Pricing Pact, Completing 17-Company Push

RFK Jr Defends Trump’s “600 Percent” Drug-Price Math as Trump Backs Explanation

RFK Jr. Defends Trump’s Drug-Price Math as Fact-Checkers Call It Wrong

CMS Pauses Medicare GLP-1 Pilot After Insurers Balk, Sets 2026–27 Bridge

Senators Press Kennedy on TrumpRx Deals and Tariff Breaks in Testy Hearing

Never miss stories about

Drug Pricing

Germany Rules No Added Benefit for New Alzheimer Antibodies After Major Review Finds Little Effect

Senate Report Says Drugmakers Raised Prices Despite Trump Deals

Dosing Disputes, Counterfeits, and a Patent Wall Put Keytruda Under Fresh Scrutiny

Keytruda’s Price Faces New Scrutiny in Germany After Spending Tops €2 Billion

Trump Imposes Up to 100% Tariffs on Patented Drugs With Paths to Lower Rates

AbbVie, Genentech Join TrumpRx With Deep Discounts on Humira and Xofluza

Emcure Slashes Price of Novo’s Semaglutide Brand Poviztra by Up to 55% in India

Brazil Overhauls Obesity Drug Guidance as FDA Approves Lilly’s Daily Pill

Brazil Sets 2026 Medicine Price Caps With Three-Tier Increases Up to 3.81%

Pakistan Drug Regulator Denies Fresh Hikes for Essential Medicines

Never miss stories about

Drug Pricing